Filippinene - engelsk - FDA (Food And Drug Administration)

yung shin (philippines), inc.; distributor: yung shin (philippines), inc. - zinc oxide , myroxylon balsamum var. pereirae (royle) harms (balsam of peru) resin , benzyl benzoate - ointment - 107.5mg/18.8mg/12.5mg per g ointment

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - this product is contraindicated in those individuals who have shown hypersensitivity to any of its components.

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin 400 [iu] in 1 g - first aid antibiotic first aid to helps prevent infection in - minor cuts  - scrapes  - burns - in the eyes  - over large areas of the body - deep or puncture wounds - animal bites - serious burns - condition persists or gets worse - a rash or other allergic reaction develops

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - bacitracin 500 [usp'u] in 1 g - polycin® ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. polycin® ophthalmic ointment is contraindicated in individuals who have shown hypersensitivity to any of its components.

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn bhd - benzyl benzoate; zinc oxide; peru balsam -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn. bhd. - zinc oxide; benzyl benzoate; peru balsam -

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - first aid antibiotic first aid to help prevent infection in - minor cuts  - scrapes  - burns

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297) - first aid antibiotic first aid antibiotic first aid antibiotic first aid to help prevent infection in minor: - cuts - scrapes - burns

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), bacitracin zinc (unii: 89y4m234es) (bacitracin - unii:58h6rwo52i) - first aid antibiotic first aid to help prevent infection in minor • cuts • scrapes • burns

USA - engelsk - NLM (National Library of Medicine)

nucare pharamceuticals,inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), prilocaine (unii: 046o35d44r) (prilocaine - unii:046o35d44r) - lidocaine 25 mg in 1 g - lidocaine 2.5% and prilocaine 2.5% cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on: - normal intact skin for local analgesia. - genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. lidocaine 2.5% and prilocaine 2.5% cream is not recommended in any clinical situation when penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effects observed in animal studies (see warnings). lidocaine 2.5% and prilocaine 2.5% cream (lidocaine 2.5% and prilocaine 2.5%) is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type or to any other component of the product.